The second-largest insurer in the United States, Aetna, has agreed to lower the costs of pharmaceutical drugs to people living with HIV/AIDS after legal action by the AIDS Institute (TAI) and The National Health Law Program (NHeLP).
NHeLP and TAI filed a complaint in May 2014 with the U.S. Department of Health and Human Services Office for Civil Rights, charging four Florida health plans, including Aetna, with unlawful discrimination against people living with HIV and AIDS.
Aetna announced on March 26th that HIV medications would be moved to a generic brand tier in all of its plans. This will lower co-payments, which were recently $1,000 a month for some medications, to a range of $5-$100, after deductibles. These reductions will be effective June 1, 2015. Read the full article here. »